Kintor Pharmaceutical Limited (9939.HK)
HKD 1.31
(9.17%)
HKD 1.31
(9.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.47 CNY | 2.37% |
| 2022 | -2.53 CNY | -7.2% |
| 2021 | -2.36 CNY | -43.9% |
| 2020 | -1.64 CNY | -69.07% |
| 2019 | -0.97 CNY | -94.0% |
| 2018 | -0.50 CNY | -108.33% |
| 2017 | -0.24 CNY | 17.24% |
| 2016 | -0.29 CNY | -326.47% |
| 2015 | -0.07 CNY | -19.3% |
| 2014 | -0.06 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q4 | -1.98 CNY | -296.0% |
| 2023 Q2 | -0.50 CNY | 55.75% |
| 2023 FY | - CNY | 2.37% |
| 2022 FY | - CNY | -7.2% |
| 2022 Q4 | -1.13 CNY | 20.42% |
| 2022 Q2 | -1.42 CNY | 0.0% |
| 2021 FY | - CNY | -43.9% |
| 2021 Q2 | -0.93 CNY | -3.33% |
| 2021 Q4 | -1.42 CNY | -52.69% |
| 2020 Q4 | -0.90 CNY | -25.0% |
| 2020 FY | - CNY | -69.07% |
| 2020 Q2 | -0.72 CNY | -33.33% |
| 2019 Q4 | -0.54 CNY | -25.58% |
| 2019 Q2 | -0.43 CNY | 0.0% |
| 2019 FY | - CNY | -94.0% |
| 2018 FY | - CNY | -108.33% |
| 2017 FY | - CNY | 17.24% |
| 2017 Q4 | -0.12 CNY | 0.0% |
| 2017 Q2 | -0.12 CNY | -79.91% |
| 2016 Q4 | -0.07 CNY | 69.68% |
| 2016 Q2 | -0.22 CNY | 0.0% |
| 2016 FY | - CNY | -326.47% |
| 2015 FY | - CNY | -19.3% |
| 2014 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 22352.252% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 137322.222% |